These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
317 related articles for article (PubMed ID: 23135165)
1. Patterns of symptom reporting during pregnancy comparing opioid maintained and control women. Gordon AL; Lopatko OV; Stacey H; Pearson V; Woods A; Fisk A; White JM J Addict Med; 2012 Dec; 6(4):258-64. PubMed ID: 23135165 [TBL] [Abstract][Full Text] [Related]
2. Development of a substance abuse program for opioid-dependent nonurban pregnant women improves outcome. Meyer M; Benvenuto A; Howard D; Johnston A; Plante D; Metayer J; Mandell T J Addict Med; 2012 Jun; 6(2):124-30. PubMed ID: 22517450 [TBL] [Abstract][Full Text] [Related]
3. Buprenorphine and methadone treatment of opiate dependence during pregnancy: comparison of fetal growth and neonatal outcomes in two consecutive case series. Kakko J; Heilig M; Sarman I Drug Alcohol Depend; 2008 Jul; 96(1-2):69-78. PubMed ID: 18355989 [TBL] [Abstract][Full Text] [Related]
4. Delayed villous maturation in term placentas exposed to opioid maintenance therapy: a retrospective cohort study. Serra AE; Lemon LS; Mokhtari NB; Parks WT; Catov JM; Venkataramanan R; Caritis SN Am J Obstet Gynecol; 2017 Apr; 216(4):418.e1-418.e5. PubMed ID: 28024988 [TBL] [Abstract][Full Text] [Related]
5. [Pregnant opioid addicted patients and additional drug intake. Part I. Toxic effects and therapeutic consequences]. Hoell I; Havemann-Reinecke U Med Monatsschr Pharm; 2011 Oct; 34(10):363-74; quiz 375-6. PubMed ID: 22010420 [TBL] [Abstract][Full Text] [Related]
6. Transitioning from methadone to buprenorphine maintenance in management of opioid use disorder during pregnancy. Johnson S; Martin PR Am J Drug Alcohol Abuse; 2018; 44(3):310-316. PubMed ID: 28829626 [TBL] [Abstract][Full Text] [Related]
7. The effects of prenatal exposure to buprenorphine or methadone on infant visual evoked potentials. Whitham JN; Spurrier NJ; Sawyer MG; Baghurst PA; Taplin JE; White JM; Gordon AL Neurotoxicol Teratol; 2010; 32(2):280-8. PubMed ID: 19751825 [TBL] [Abstract][Full Text] [Related]
8. Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome. Jones HE; Johnson RE; Jasinski DR; O'Grady KE; Chisholm CA; Choo RE; Crocetti M; Dudas R; Harrow C; Huestis MA; Jansson LM; Lantz M; Lester BM; Milio L Drug Alcohol Depend; 2005 Jul; 79(1):1-10. PubMed ID: 15943939 [TBL] [Abstract][Full Text] [Related]
9. Neonatal outcomes following in utero exposure to methadone or buprenorphine: a National Cohort Study of opioid-agonist treatment of Pregnant Women in Norway from 1996 to 2009. Welle-Strand GK; Skurtveit S; Jones HE; Waal H; Bakstad B; Bjarkø L; Ravndal E Drug Alcohol Depend; 2013 Jan; 127(1-3):200-6. PubMed ID: 22841456 [TBL] [Abstract][Full Text] [Related]
10. Breastfeeding rates and the relationship between breastfeeding and neonatal abstinence syndrome in women maintained on buprenorphine during pregnancy. O'Connor AB; Collett A; Alto WA; O'Brien LM J Midwifery Womens Health; 2013; 58(4):383-8. PubMed ID: 23931660 [TBL] [Abstract][Full Text] [Related]
11. Chronic opioid use during pregnancy: maternal and fetal implications. Stanhope TJ; Gill LA; Rose C Clin Perinatol; 2013 Sep; 40(3):337-50. PubMed ID: 23972743 [TBL] [Abstract][Full Text] [Related]
12. Patterns of symptom complaints in methadone maintenance patients. Dyer KR; White JM Addiction; 1997 Nov; 92(11):1445-55. PubMed ID: 9519488 [TBL] [Abstract][Full Text] [Related]
13. Association between prenatal tobacco exposure and outcome of neonates born to opioid-maintained mothers. Implications for treatment. Winklbaur B; Baewert A; Jagsch R; Rohrmeister K; Metz V; Aeschbach Jachmann C; Thau K; Fischer G Eur Addict Res; 2009; 15(3):150-6. PubMed ID: 19420947 [TBL] [Abstract][Full Text] [Related]
14. Outpatient comparison of buprenorphine and methadone maintenance. I. Effects on opiate use and self-reported adverse effects and withdrawal symptomatology. Johnson RE; Fudala PJ; Jaffe JH NIDA Res Monogr; 1990; 105():585-6. PubMed ID: 1876130 [No Abstract] [Full Text] [Related]
15. Maternal Opioid Treatment: Human Experimental Research (MOTHER) Study: maternal, fetal and neonatal outcomes from secondary analyses. Bandstra ES Addiction; 2012 Nov; 107 Suppl 1():1-4. PubMed ID: 23106922 [No Abstract] [Full Text] [Related]
16. A Retrospective Cohort Study of Birth Outcomes in Neonates Exposed to Naltrexone in Utero: A Comparison with Methadone-, Buprenorphine- and Non-opioid-Exposed Neonates. Kelty E; Hulse G Drugs; 2017 Jul; 77(11):1211-1219. PubMed ID: 28536981 [TBL] [Abstract][Full Text] [Related]
17. "Should I stay or should I go?" Coming off methadone and buprenorphine treatment. Winstock AR; Lintzeris N; Lea T Int J Drug Policy; 2011 Jan; 22(1):77-81. PubMed ID: 20956077 [TBL] [Abstract][Full Text] [Related]
18. Treatment of opioid dependence in the setting of pregnancy. Young JL; Martin PR Psychiatr Clin North Am; 2012 Jun; 35(2):441-60. PubMed ID: 22640765 [TBL] [Abstract][Full Text] [Related]
19. [Withdrawal syndromes of newborns of pregnant drug abusers maintained under methadone or high-dose buprenorphine: 246 cases]. Lejeune C; Aubisson S; Simmat-Durand L; Cneude F; Piquet M; Gourarier L; Ann Med Interne (Paris); 2001 Nov; 152 Suppl 7():21-7. PubMed ID: 11965095 [TBL] [Abstract][Full Text] [Related]
20. Randomized controlled study transitioning opioid-dependent pregnant women from short-acting morphine to buprenorphine or methadone. Jones HE; Johnson RE; Jasinski DR; Milio L Drug Alcohol Depend; 2005 Apr; 78(1):33-8. PubMed ID: 15769555 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]